Chunghwa Chemical Synthesis & Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 765.45 million compared to TWD 529.53 million a year ago. Net income was TWD 179.24 million compared to TWD 127.66 million a year ago.

Basic earnings per share from continuing operations was TWD 2.31 compared to TWD 1.65 a year ago. Diluted earnings per share from continuing operations was TWD 2.29 compared to TWD 1.63 a year ago.